NCT00030602View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2000

Primary Completion Date

December 31, 2001

Study Completion Date

December 31, 2001

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

PSA prostate cancer vaccine

BIOLOGICAL

incomplete Freund's adjuvant

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT00030602 - Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter